Semaglutide Overview
Semaglutide Structure: Peptide Composition and Molecular Details
The peptide structure of Semaglutide is critical to its efficacy as a GLP-1 analog for diabetes management and weight loss.
Its detailed molecular composition is as follows:
- Sequence: H-HGEGTFTSDVSSYLEGQAAK-OH stearic diacid-EFIAWLVRGRG-OH
- Molecular Formula: C187H291N45O59
- Molecular Weight: 4113.64 g/mol
- PubChem CID: 56843331
- CAS Number: 910463-68-2
- Synonyms: Semaglutide, Ozempic, Rybelsus, NN9535
The sequence includes a modification with stearic diacid, which enhances Semaglutide’s stability and duration of action, making it highly effective for targeting GLP-1 receptors to support insulin secretion and metabolic health. Note: A visual representation of the molecular structure is available for detailed analysis (Source: PubChem).
Keywords: Semaglutide, GLP-1 analog, diabetes management, weight loss, insulin secretion, Alzheimer’s prevention, heart health, peptide structure, metabolic health, obesity treatment.
Reviews
There are no reviews yet.